Selective costimulatory blockade in chronic graft vs. host disease (cGVHD): CD86 blockade inhibits donor CD4+T cell activation whereas CD80 blockade promotes donor CD8+T cell expansion and activation

被引:0
作者
Lang, TJ
Nguyen, P
Gause, W
Via, CS
机构
[1] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
[2] Baltimore VA Med Ctr, Baltimore, MD 21201 USA
[3] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:A614 / A614
页数:1
相关论文
共 50 条
[41]   2B4 Induced by Selective CD28 Blockade Functionally Regulates Alloreactive Memory CD8+T Cell Responses [J].
Liu, D. ;
Krummey, S. ;
Suchard, S. ;
Nadler, S. ;
Ford, M. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 :143-143
[42]   Inflammasome activation occurs in CD4+and CD8+T cells during graft-versus-host disease [J].
Talley, Sarah ;
Campbell, Edward .
JOURNAL OF IMMUNOLOGY, 2023, 210 (01)
[43]   IL-6 BLOCKADE WITH TOCILIZUMAB DOES NOT SUPPRESS CD4+T CELL ACTIVATION AT 48 WEEKS OF THE TREATMENT [J].
Murakami, M. ;
Kuritani, T. ;
Nishimoto, N. .
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 :731-731
[44]   Acceptance of immunogenic hepatocyte allografts under cover of donor specific transfusion and costimulatory blockade with anti-CD40L mAb requires host CD8+T cells. [J].
Lunsford, KE ;
Gao, DH ;
Bumgardner, GL .
HEPATOLOGY, 2003, 38 (04) :165A-165A
[45]   Expression of molecules involved in antigen presentation and T cell activation (HLA-DR, CD80, CD86, CD44 and CD54) by cultured human osteoblasts [J].
Reyes-Botella, C ;
Montes, MJ ;
Vallecillo-Capilla, MF ;
Olivares, EG ;
Ruiz, C .
JOURNAL OF PERIODONTOLOGY, 2000, 71 (04) :614-617
[46]   The critical role of CD4 T cells in CD154 blockade-resistant memory CD8 T cell activation and allograft rejection in sensitized recipients [J].
Wang, Yue ;
Wu, Zheng ;
Busuttil, Ronald W. ;
Zhai, Yuan ;
Kupiec-Weglinski, Jerzy W. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 :314-314
[47]   GENE EXPRESSION IN CD4+T CELLS OF PATIENTS WITH AND WITHOUT CHRONIC GRAFT-VS-HOST DISEASE (CGVHD) [J].
Tabellini, L. ;
Fan, W. ;
Zhao, L. P. ;
Bumgarner, T. E. ;
Flowers, M. E. ;
Grogan, B. M. ;
Warren, H. E. ;
Lee, S. J. ;
Martin, P. J. ;
Hansen, J. A. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) :S338-S338
[48]   Prevention and treatment of chronic murine graft-vs-host disease by blockade of CD28 mediated T cell costimulation. [J].
Sullivan, L ;
Calzetta, A ;
Robertson, N ;
Smith, S .
ARTHRITIS AND RHEUMATISM, 1997, 40 (09) :1076-1076
[49]   Blockade of osteopontin reduces alloreactive CD8+ T cell-mediated graft-versus-host disease [J].
Zhao, Fang ;
Zhang, Yi ;
Wang, Hao ;
Jin, Min ;
He, Shan ;
Shi, Yufang ;
Guo, Yajun ;
Zhang, Yanyun .
BLOOD, 2011, 117 (05) :1723-1733
[50]   Cytoprotective effects of high dose of α-galactosylceramide against activation-induced CD4+T and CD8+T cell death as an adjuvant [J].
Qian, Gaochao ;
Jin, Wentao ;
Tian, Xiaojing ;
Ding, Zhixiang ;
Shi, Bingwei ;
Zhang, Qi .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (05) :5026-5034